Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F5V8U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,239
Award facts
- Contract value 100% obligated
- $17,238.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,238.81 to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 20, 2026, for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. This is a firm fixed-price, non-set-aside contract with a completion date of January 21, 2026, and performance will be executed from the contractor's location in Conshohocken, Pennsylvania. The delivery order was awarded competitively under Amerisourcebergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 vehicle that extends through December 2026 and authorizes the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Amerisourcebergen Drug Corp operates as a subsidiary of parent company Cencora, Inc. (doing business as Amerisourcebergen), a major pharmaceutical distributor serving federal agencies including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contracting history demonstrates its capability to efficiently deliver critical pharmaceutical commodities across multiple therapeutic domains to military treatment facilities and federal healthcare systems. This delivery order for RINVOQ ER, a prescription pharmaceutical used in the treatment of rheumatoid arthritis and other inflammatory conditions, represents a routine fulfillment under the larger strategic pharmaceutical supply agreement with the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DR26F5V8U?
SPE2DR26F5V8U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F5V8U worth?
The government has obligated $17,239 on SPE2DR26F5V8U.
Is contract SPE2DR26F5V8U an order under another contract?
Yes. SPE2DR26F5V8U is a delivery order under SPE2DR25D3404, an indefinite delivery contract.
Was contract SPE2DR26F5V8U competed?
The extent of competition for SPE2DR26F5V8U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award